Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
Germany
Pediatrics III, West German Cancer Centre, University Hospital, Essen Universitätsklinikum, Klinik für Kinder- und Jugendmedizin, Frankfurt am Main Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum, Freiburg im Breisgau University Children's Hostpital, Tübingen Age range
2 Years – 40 Years
Last updated December 2024